ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Genetic Analysis of Platelet-Related Genes in Hepatocellular Carcinoma Reveals a Novel Prognostic Signature and Determines PRKCD as the Potential Molecular Bridge

Li, Xiangyu; Zhao, Kai; Lu, Yun; Wang, Jianming*; Yao, Wei*华中科技大学
BIOLOGICAL PROCEDURES ONLINE2022-12-3DOI: 10.1186/s12575-022-00185-9
5被引8阅读
引用收藏
分享

摘要

Background Hepatocellular carcinoma (HCC) belongs to a representative lethality gastrointestinal malignancy, and comprehensive management of HCC remains intractable at present on account of its invasive biological feature that is easy to relapse and early metastasis. The intimate connection between platelets and tumor progression has been widely reported, and platelet-related indicators are also used in the clinical practice of carcinoma. This work is designed to investigate the significance of platelet-related genes in the prognostic prediction of patients with HCC and their potential role in the cross-talk between HCC cells and platelets in the tumor microenvironment. Methods By integrating the RNA-seq data and clinicopathological information of HCC patients, we extracted prognosis-associated platelet-related genes based on the univariate cox analysis and further established a relevant prognostic signature via the lasso cox regression analysis, and two independent HCC cohorts were used as external validation. Multiple bioinformatics methods were utilized to explore the underlying functional discrepancy between different risk groups classified by the risk model. And in vitro proliferation, invasion, and migration assays were conducted to investigate the effect of platelet stimulation on HCC cells' viability and motility, and flow cytometric analysis was exerted to demonstrate the influence of HCC cells on platelet activation. Results A novel platelet-related risk model was developed and patients both in the training and testing cohorts were divided into distinct risk subgroups according to the median risk score. It was observed that the high-risk status was closely associated with poor prognosis and worse clinicopathological parameters. Meanwhile, an obvious discrepancy in the constitution of the immune microenvironment also indicated that distinct immune status might be a potential determinant affecting prognosis as well as immunotherapy reactiveness. Moreover, in vitro experiments demonstrated that PRKCD could act as a molecular bridge between tumor cells and platelets, which could either participate in regulating tumor malignant phenotype or mediating platelet activation. Conclusions In brief, this work reveals a novel platelet-related risk signature for prognostic evaluation of HCC patients and confirms that PRKCD is a key messenger in HCC cell-platelet interaction and plays a crucial role in mediating platelet-induced tumor progression.

学科与关键词

关键词
PlateletHepatocellular carcinomaPRKCDCross-talkPrognosisImmunity
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
BIOLOGICAL PROCEDURES ONLINE
发表日期
2022-12-03
卷期
第 24 卷, 第 1 期
页码
22
DOI
10.1186/s12575-022-00185-9
语言
ENGLISH
期刊等级
4区
成果收录
SCIE
资助标注
Youth Program of National Natural Science Foundation of China; National Natural Science Foundation of China; [81902439]; [81874062]; [82072730]

作者

  • L

    Li, Xiangyu (第一作者)

    huazhong univ sci & technol

  • Z

    Zhao, Kai

    huazhong univ sci & technol

查看全部 5 位作者收起作者
  • L

    Lu, Yun

    huazhong univ sci & technol

  • W

    Wang, Jianming (通讯)

    wuhan univ sci & technol · huazhong univ sci & technol

  • Y

    Yao, Wei (通讯)

    huazhong univ sci & technol

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417